期刊文献+

IL-1B及IL-1RN基因多态性与江苏地区宫颈癌遗传易感性相关 被引量:2

Associations between functional genetic polymorphisms of IL-1B and IL-1RN and risk of cervical cancer
下载PDF
导出
摘要 目的:探讨炎症因子IL-1B(T-31C和C-511T)及其拮抗基因IL-1RN基因多态性与宫颈癌遗传易感性的关系。方法:采用病例对照研究,对经组织学确诊的宫颈癌新发病例273例按年龄和城乡频数匹配正常对照402例,以聚合酶链反应-限制性片段长度多态性(PCR-RFLP)方法进行多态性检测,比较不同基因型与宫颈癌发病风险的关系。结果:在调整年龄、城乡等因素后,携带-511CT基因型比携带CC基因型个体发生宫颈癌的危险性增加93%(调整OR=1.93,95%CI=1.00~3.72);携带-511TT基因型比携带-511CC基因型个体发生宫颈癌的危险性增加115%(调整OR=2.15,95%CI=1.02~4.53)。分层分析表明,携带IL-1BT-31C变异基因型的个体发生宫颈癌的风险仅在年龄≥50岁(调整OR=1.72,95%CI=1.01~2.93)、妊娠次数≥2次(调整OR=1.83,95%CI=1.07~3.11)和农村地区女性(调整OR=1.63,95%CI=1.04~2.54)中显著。IL-1RN各基因型在病例组和对照组中分布的差异均无统计学意义。结论:IL-1BC-511T多态性可能与江苏地区妇女的宫颈癌易感性相关。 Objective:To study the relationship between functional genetic variants of IL-1B (T-31C,C-511T) and IL-1RN genes and the susceptibility of cervical cancer. Methods:The case-control study was conducted in Jiangsu female population,including 273 cervical cancer cases and 402 cancer-free controls frequency-matched by age and residential areas. Genotypes were determined by PCR-the restriction length polymorphism(PCR-RFLP) assays. Results: The differences of IL-1B T-31C and C-511T genotype frequen- cies between cases and controls were not statistically significant. After adjusted age and residences, the Logistic regression analysis revealed that the increased risk of cervical cancer was associated with IL-1B -511TT and -511CT variant genotypes (OR=1.93,95% CI= 1.00-3.72 for CT genotypes ; OR=2.15,95% CI=1.02-4.53 for TT genotypes), compared with the -511CC genotype. Stratified analysis indicated that IL-1B T-31C variant genotypes were statistically associated with cervical cancer risk in the subjects with more than 49 years old (OR=1.72,95%CI=1.01-2.93),pregnancy frequency ≥2 (OR=1.83,95%CI=1.07-3.11) and living in countryside (OR= 1.63,95%CI=1.04-2.54). No significant association was observed between polymorphisms of IL-1RN gene and cervical cancer risk. Conclusion:These findings supported the hypothesis that the functional genetic variants of IL-1B C-511T might contribute to the cervical carcinogenesis in Jiangsu population.
出处 《南京医科大学学报(自然科学版)》 CAS CSCD 北大核心 2008年第5期629-634,共6页 Journal of Nanjing Medical University(Natural Sciences)
关键词 宫颈癌 IL-1B IL-1RN 单核苷酸多态性 分子流行病学 cervical cancer IL-1B IL-1RN polymorphism molecular epidemiology
  • 相关文献

参考文献15

  • 1Rao PH,Arias-Pulido H, Lu XY. Chromosomal amplifications, 3q gain and deletions of 2q33-q37 are the frequent genetic changes in cervical carcinoma [J]. BMC Cancer, 2004,4(1):5
  • 2Munoz N. Human papillomavirus and cancer:the epidemiological evidence [J]. J Clin Virol,2000,19 (1-2): 1-5
  • 3El-Omar EM, Carrington M, Chow WH, et al. Interleukin- 1 polymorphisms associated with increased risk of gastric cancer[J]. Nature,2000,404(6776):398-402
  • 4Sokbom K,Jae W, Noh H,et al. Interleukin- 1 Beta-511 polymorphism and risk of cervical cancer [J]. J Korean Med Sci, 2007,22(1) : 110-113
  • 5Mustea A,Sehouli J,Konsgen D,et al. Interleukin 1 receptor antagonist(IL-1 RA) Polymorphism in women with cervical cancer [J]. Anticancer Res,2003,23 (2A): 1099-1102
  • 6Yang J,Hu Z,Xu Y,et al. Interleukin-1B gene promoter variants are associated with an increased risk of gastric cancer in a Chinese population [J]. Cancer Lett, 2004,215(2) : 191-198
  • 7Hu Z, Shao M, Chen Y, et al. Allele 2 of the interleukin- 1 receptor antagonist gene(IL1RN * 2) is associated with a decreased risk of primary lung cancer [J]. Cancer Lett, 2006,236(2) : 269-275
  • 8Noqueira de Souza NC, Brenna SM,Campos F,et al. Interleukin-6 polymorphisms and the risk of cervical cancer [J]. Int J Gynecol Cancer,2006, 16(3) : 1278-1282
  • 9Tjiong MY,van der Vange N,ter Schegget JS,et al. Cytokines in cervicovaginal washing fluid from patients with cervical neoplasia[J]. Cytokine, 2001,14(6) :357-360
  • 10姜君,薛雅丽,马琳琳,张云艳,郑冬梅,王哲,白静,傅松滨.中国汉族人群IL-1 RA基因多态性及其与宫颈癌的相关性研究[J].国际遗传学杂志,2006,29(3):164-168. 被引量:3

二级参考文献21

  • 1连丽娟.林巧稚妇科肿瘤学(第2版)[M].北京:人民卫生出版社,1994.533-544.
  • 2Arend WP,Malyak M,Guturidgeo CJ,et al.Interleukin-1 antagonist:role in biology.Annu Rev Immunol,1998,16:27-55.
  • 3Arend WP.Interleukin-1 receptor antagonist:a new member of the interleukin-1 family.J Clin Invest,1991,88:1445-1451.
  • 4Arend WP.Interleukin-1 receptor antagonist:discovery,structure and properties.Prog Growth Factor Res,1990,2:193-205.
  • 5Dinarello CA.Biologic basis for interleukin-1 in disease.Blood,1996,87:2095-2147.
  • 6Witkin SS,Gerber S,Ledger WJ.Influence of interleukin-1 receptor antagonist gene polymorphism on disease.Clin Infect Dis,2002,34:204-209.
  • 7Castello G,Espositio E,Stellato G,et al.Immunological abnormalities in patients with cervical carcinoma.Ginecol Oncol,1986,25:61-64.
  • 8Schwartz LB,Cargangiu ML,Bradham L,et al.Rapidly progressive squamous cell carcinoma coexisting with human immunodeficiency virus infection:clinical opinion.Ginecol Oncol,1991,41:255-258.
  • 9Tarlow JK,Blackmore AIF,Lennard A.Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86bp tandem repeats.Hum Genet,1993,91:403-404.
  • 10Mustea A,Sehouli J,Konsgen D,et al.Interleukin-1 receptor antagonist polymorphism in women with cervical canecr.Anticancer Res,2003,239:1099-1102.

共引文献2

同被引文献14

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部